AzTrials
AzTrials

Ischemic StrokeSWORD-ITNCT01967290

Stroke Wearable Operative Rehabilitation Device Impact Trial

A study testing Vibratory feedback and 3D movement analysis and Only 3D movement analysis in people with Ischemic Stroke and Upper Extremity Hemiparesis, run by Centro Hospitalar de Entre o Douro e Vouga at 3 sites in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to determine the impact of vibratory feedback on the quality and intensity of a common motor rehabilitation task of the upper-arm (hand-to-mouth) in stroke patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ischemic Stroke, Upper Extremity Hemiparesis
What is being tested?
Vibratory feedback and 3D movement analysis and Only 3D movement analysis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
3 sitesPortugal
Study dates
May 2013to Nov 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • More than 18 years old at stroke onset, with no superior age limit;
  • Medical diagnosis of acute ischemic stroke;
  • First ever stroke;
  • Previously independent, defined as having a modified Rankin scale (mRS) of 0-1;
  • Clinical and CT or MRI compatible with a medial cerebral artery ischemic lesion;
  • Confirmed motor deficit on the upper limb but not plegia (able to actively extend wrist, thumb, and at least 2 other digits >10°), defined as a score between 0 and 2 on items 5a or 5b of the National Institute of Health Stroke Scale;
Show all 10Show fewer
  • Inpatients, within no more than 4 weeks after stroke onset;
  • Medically stable, no intravenous medication and already able to sit for more than one hour comfortably;
  • Favourable opinion of the attending stroke physician;
  • Patient and caregiver understand the purpose of the study and provided written informed consent.

Who cannot join

  • No detectable motor deficits at baseline assessment by the neurologist;
  • Severe aphasia;
  • Dementia (any stage);
  • Other cognitive or psychiatric comorbidity that impairs communication or compliance with the tasks;
  • Severe respiratory or cardiac condition incompatible with more than one minute of continuous mild exercise (e.g. combing hair) in a sitting position;
  • Pain that limits upper limb movement either on the normal or affected side;
Show all 9Show fewer
  • Upper limb amputation or severe deformity either on the normal or affected side;
  • Fixed articular limitations of upper limb either on the normal or affected side;
  • Enrollment in other trial in the previous 3 months.

Trial locations and contacts

3 sites in 1 country.

Portugal3 sites
  • Rehabilitation Department, Centro Hospitalar do Alto Ave, EPE

    Guimarães, 4835-044

  • Neurology Department, CHEDV

    Santa Maria da Feira, 4520-211

  • Rehabilitation Department, CHEDV

    Santa Maria da Feira, 4520-211

Other trials in Portugal

About this study

Official title: Phase II Study of the Impact of the SWORD Device on Rehabilitation Tasks Performance in the Early Post Stroke Period

The objective of this study is to determine the impact of vibratory feedback on the quality and intensity of a common motor rehabilitation task of the upper-arm (hand-to-mouth) in stroke patients. For that purpose the investigators use the SWORD system that combines 3D motion quantification wearable sensors and a vibratory module.

The investigators hypothesize that vibratory stimuli during a motor rehabilitation task increase significantly the number of correct movements performed per unit of time.

The design of the study is a cross-over randomized clinical trial. With the SWORD system in place each patient will perform the hand-to-mouth task twice (with vibratory feedback and without it), the order being random. The number of correct movements and other motor outcomes will be assessed continuously under both conditions.

Being tested
Vibratory feedback and 3D movement analysis, Only 3D movement analysis
Keywords
stroke, motor deficits, motor rehabilitation, neurorehabilitation, medical devices, wearable devices, e-health systems
Medical subject headings
Ischemic Stroke, Stroke, Neurologic Manifestations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vibratory feedback and 3D movement analysisDevice

    Also called Propriocetive actuation, Vibratory stimulation, SWORD, Stroke Wearable Operative Rehabilitation Device

    Hand-to-mouth task performed under vibratory feedback combined with 3D continuous movement analysis.

  • Only 3D movement analysisDevice

    Also called 3D movement quantification, 3D movement characterization, SWORD, Stroke Wearable Operative Rehabilitation Device

    Hand-to-mouth task performed under 3D continuous movement analysis only

Study groups in NCT01967290
Study groupRoleWhat they receive
Hand-to-mouth task - vibratory feedbackExperimentalHand-to-mouth task under vibratory feedback and 3D movement analysis. The SWORD device is in place over the patient arm, performs continuous 3D movement analysis and provides vibratory feedback according to quality performance settings established by the clinician after patient assessment. If movement is of lower amplitude or slower than prescribed a vibratory stimulus is delivered at the wrist of the patient. The intervention is repeated on the hemiparetic and normal sides and the duration of the task is defined according to the patient cardiovascular status.
Receives: Device: Vibratory feedback and 3D movement analysis
Hand-to-mouth task - no vibratory feedbackActive comparatorHand-to-mouth task in the same conditions as the experimental arm but without vibratory feedback, only 3D movement analysis. The SWORD device is in place over the patient arm, performs continuous 3D movement analysis but does not provides vibratory feedback according to quality performance settings established by the clinician after patient assessment. If movement is of lower amplitude or slower than prescribed NO vibratory stimulus is delivered at the wrist of the patient. The intervention is repeated on the hemiparetic and normal sides and the duration of the task is defined according to the patient cardiovascular status.
Receives: Device: Only 3D movement analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of correct movements

    Number of correct movements performed within the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task.

Secondary outcomes (9)
  1. Total number of movements

    Total number of correct and incorrect movements performed within the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task.

  2. Range of motion in degrees

    Average, standard deviation and variance of the range of motion, measured in degrees, of all the correct movements performed during the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task.

  3. Time between correct movements in seconds

    Average, standard deviation and variance of the time between correct movements, measured in seconds, of all the correct movements performed during the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task.

  4. Cumulative amplitude of correct movements in degrees

    Sum of the amplitudes of all correct movements performed within the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task

  5. Cumulative amplitude of all movements performed in degrees

    Sum of the amplitudes of all correct and incorrect movements performed within the duration of each hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task.

  6. Number of pause events during the task

    Number of episodes during the execution of each hand-to-mouth task where the patient stopped doing movements and/or the time between correct movements exceeded the mean plus one standard deviation measured within the same hand-to-mouth task.

    Measured: At the end of each hand-to-mouth task

  7. Fatigue

    Assessment of fatigue by the patient through an analogic scale from 0 (no fatigue) to 4 (interruption due to fatigue).

    Measured: At the end of each hand-to-mouth task.

  8. Pain

    Assessment of pain by the patient through an analogic scale from 0 (no pain) to 4 (interruption due to pain).

    Measured: At the end of each hand-to-mouth task.

  9. Number and type of other distresses

    Recording and description of any kind of discomfort reported by the patient or detected through vital parameter and arterial oxygen saturation monitoring.

    Measured: At the end of each hand-to-mouth task.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionOct 2013
  4. Study completionNov 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01967290
Sponsor's protocol ID
PTDC/SAU-NEU/102075/2008_SWORD
Acronym
SWORD-IT
Status last verified
Nov 2013
First submitted
18 Oct 2013
Last updated
28 Nov 2013
Results posted
No
Data monitoring committee
No

Publications

  • Bento VF, Cruz VT, Ribeiro DD, Cunha JP. The vibratory stimulus as a neurorehabilitation tool for stroke patients: proof of concept and tolerability test. NeuroRehabilitation. 2012;30(4):287-93. doi: 10.3233/NRE-2012-0757.

    PubMed 22672942
  • Bento VF, Cruz VT, Ribeiro DD, Cunha JP. Towards a movement quantification system capable of automatic evaluation of upper limb motor function after neurological injury. Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:5456-60. doi: 10.1109/IEMBS.2011.6091392.

    PubMed 22255572
  • Bento VF, Cruz VT, Ribeiro DD, Colunas MM, Cunha JP. The SWORD tele-rehabilitation system. Stud Health Technol Inform. 2012;177:76-81.

    PubMed 22942034
  • Bento VF, Cruz VT, Ribeiro DD, Branco C, Coutinho P. The potential of motion quantification systems in the automatic evaluation of motor function after stroke. Int J Stroke. 2013 Aug;8(6):E37. doi: 10.1111/ijs.12111. No abstract available.

    PubMed 23879761
  • Cruz VT, Bento V, Ruano L, Ribeiro DD, Fontao L, Mateus C, Barreto R, Colunas M, Alves A, Cruz B, Branco C, Rocha NP, Coutinho P. Motor task performance under vibratory feedback early poststroke: single center, randomized, cross-over, controlled clinical trial. Sci Rep. 2014 Jul 11;4:5670. doi: 10.1038/srep05670.

    PubMed 25011667

Questions about this trial

What is this clinical trial studying?

A study testing Vibratory feedback and 3D movement analysis and Only 3D movement analysis in people with Ischemic Stroke and Upper Extremity Hemiparesis, run by Centro Hospitalar de Entre o Douro e Vouga at 3 sites in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Nov 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of correct movements (time frame: At the end of each hand-to-mouth task.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01967290, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in